Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Royalty Pharma EVP Research & Investments Marshall Urist sells 4,126 shares for $238,812.88

Royalty Pharma EVP Research & Investments Marshall Urist sells 4,126 shares for $238,812.88

BitgetBitget2026/09/30 20:33
  • Marshall Urist, EVP, Research & Investments, sold 4,126 Royalty Pharma Class A ordinary shares on Sept. 28, 2026.
  • Sale priced at USD 57.88 per share.
  • Direct holdings fell to 4,126 shares.
  • Indirect holdings include 19,020 shares held by an IRA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001838139-26-000026), on September 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!